Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Angela Damato
Observed names:
A Damato,
A. Damato,
D'AMATO, Angela,
DAMATO, ANGELA,
Damato, Angela
Institutions:
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Azienda Sanitaria Unità Locale di Reggio Emilia
Observed institutions:
University of Siena,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Azienda Sanitaria Unità Locale di Reggio Emilia,
Santa Maria Nuova Hospital,
Fondazione IRCCS Istituto Nazionale dei Tumori,
Instituto Nazionale Tumori Regina Elena,
Temple University
show all 7
ORCID:
0000-0001-8286-1274
Observed ORCID:
0000-0001-8286-1274
OpenAlex ID:
A5014770379
CDK9 inhibitors in acute myeloid leukemia
2018
·
Silvia Boffo
, Angela Damato
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
171
PDF
Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs)
2016
·
Marcello Tiseo
, Angela Damato
, et al.
·
Lung Cancer
·
53
Five-year relative survival by stage of breast and colon cancers in northern Italy
2022
·
Lucia Mangone
, Francesco Marinelli
, et al.
·
Frontiers in Oncology
·
41
PDF
The clinical relevance of multiple DPYD polymorphisms on patients candidate for fluoropyrimidine based-chemotherapy. An Italian case-control study
2019
·
Francesco Iachetta
, Candida Bonelli
, et al.
·
British Journal of Cancer
·
39
PDF
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC-03-2018)
2020
·
Angela Damato
, Francesco Iachetta
, et al.
·
BMC Cancer
·
34
PDF
Chemotherapy Duration for Various Indications in Colorectal Cancer: a Review
2023
·
Angela Damato
, Michele Ghidini
, et al.
·
Current Oncology Reports
·
26
Phase II study of nivolumab in combination with FOLFOXIRI/bevacizumab as first-line treatment in patients with advanced colorectal cancer RAS/BRAF mutated (mut): NIVACOR trial (GOIRC-03-2018).
2022
·
Angela Damato
, Francesca Bergamo
, et al.
·
Journal of Clinical Oncology
·
23
FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial
2021
·
Angela Damato
, Francesca Bergamo
, et al.
·
Frontiers in Oncology
·
21
PDF
SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia
2020
·
Carmine Pinto
, Annalisa Berselli
, et al.
·
Biology
·
17
PDF
Abdominal Fat Characteristics and Mortality in Rectal Cancer: A Retrospective Study
2023
·
Massimo Pellegrini
, Giulia Besutti
, et al.
·
Nutrients
·
16
PDF
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03)
2018
·
Carmine Pinto
, Maurizio Di Bisceglie
, et al.
·
The Oncologist
·
16
Impact of Multidisciplinary Team Management on Survival and Recurrence in Stage I–III Colorectal Cancer: A Population-Based Study in Northern Italy
2024
·
Lucia Mangone
, Maurizio Zizzo
, et al.
·
Biology
·
15
PDF
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM)
2022
·
D. Ciardiello
, C. Chiarazzo
, et al.
·
ESMO Open
·
15
PDF
Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients
2021
·
Giulia Besutti
, Angela Damato
, et al.
·
BMC Cancer
·
14
PDF
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies
2022
·
Anna Maria Rachiglio
, Laura Forgione
, et al.
·
Cancers
·
11
PDF
Safety Profile and Treatment Response of Everolimus in Different Solid Tumors: An Observational Study
2014
·
Elena Verzoni
, Sara Pusceddu
, et al.
·
Future Oncology
·
10
Malignant pheochromocytoma and paraganglioma: future considerations for therapy.
2013
·
R Buzzoni
, S Pusceddu
, et al.
·
PubMed
·
10
A Population-Based Study of Cardiovascular Disease Mortality in Italian Cancer Patients
2021
·
Lucia Mangone
, Pamela Mancuso
, et al.
·
Cancers
·
8
PDF
The Effect of Diffuse Liver Diseases on the Occurrence of Liver Metastases in Cancer Patients: A Systematic Review and Meta-Analysis
2021
·
Filippo Monelli
, Giulia Besutti
, et al.
·
Cancers
·
8
PDF
Preliminary safety analysis of phase II open-label NIVACOR trial (GOIRC-03-2018) in patients with advanced colorectal cancer RAS or BRAF mutated.
2021
·
Angela Damato
, Annalisa Berselli
, et al.
·
Journal of Clinical Oncology
·
8
Phase III Study with FOLFIRI + Cetuximab Versus FOLFIRI + Cetuximab Followed by Cetuximab Alone in RAS and BRAF WT mCRC
2018
·
Carmine Pinto
, Nicola Normanno
, et al.
·
Future Oncology
·
7
Well-differentiated neuroendocrine tumor of tailgut cyst. A rare entity with controversial medical opportunities
2013
·
Angela Damato
, Sara Pusceddu
, et al.
·
Tumori Journal
·
7
Characteristics and Outcomes of Colorectal Cancer Patients Cared for by the Multidisciplinary Team in the Reggio Emilia Province, Italy
2024
·
Lucia Mangone
, Francesco Marinelli
, et al.
·
Cancers
·
6
PDF
New Potential Immune Biomarkers in the Era of Precision Medicine: Lights and Shadows in Colorectal Cancer
2022
·
Angela Damato
, Martina Rotolo
, et al.
·
Life
·
6
PDF
NIVACOR: Phase II study of nivolumab in combination with FOLFOXIRI/bevacizumab in first-line chemotherapy for advanced colorectal cancer RASm/BRAFm patients.
2020
·
Angela Damato
, Francesco Iachetta
, et al.
·
Journal of Clinical Oncology
·
6
Show more works
View as search
Works count:
78
Citation count:
615
H-index:
14
I10-index:
17
Year
Topic
Type